A novel transurethral resection technique for superficial bladder tumor: retrograde en bloc resection

Kai-Yan Zhang, Jin-Chun Xing, Wei Li, Zhun Wu, Bin Chen, Dong-Yu Bai, Kai-Yan Zhang, Jin-Chun Xing, Wei Li, Zhun Wu, Bin Chen, Dong-Yu Bai

Abstract

Background: Transurethral resection of bladder tumor (TURBT) is the standard approach to bladder tumors but suffers from several disadvantages. The aim of this study was to evaluate the safety and efficacy of a novel procedure of retrograde en bloc resection of bladder tumor (RERBT) with conventional monopolar resection electrode for the treatment of superficial bladder tumors.

Methods: RERBT and conventional TURBT (C-TURBT) were conducted, respectively, in 40 and 50 patients diagnosed with superficial papillary bladder tumors. In the RERBT group, the tumors were en bloc removed retrogradely under direct vision using a conventional monopolar electrode. Patients' clinicopathological, intraoperative, and postoperative data were compared retrospectively between the RERBT and C-TURBT groups.

Results: Of the 90 patients, 40 underwent RERBT and 50 underwent C-TURBT. Both groups were comparable in clinicopathological characteristic. RERBT could be performed as safely and effectively as C-TURBT. There were no significant differences in operative time and surgical complications. The cumulative recurrence rates between groups were similar during up to 18 months follow-up. The detrusor muscle could be identified pathologically in 100% of RERBT tumor specimens and the biopsy of tumor bases, but only in 54 and 70%, respectively, of C-TURBT samples (P < 0.01).

Conclusions: The RERBT technique is feasible and safe for superficial bladder tumors using conventional monopolar resection setting, with the advantages of adequate tumor resection and the ability to collect good quality tumor specimens for pathological diagnosis and staging compared to conventional TURBT.

Keywords: En-bloc resection; Non-muscle-invasive bladder cancer; Transurethral resection of bladder tumor.

Conflict of interest statement

Ethics approval and consent to participate

This study was approved by the Ethics Committee of Xiamen University Affiliated First Hospital.

Consent for publication

All patients enrolled in the study signed the consent for publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
a A 1.5-cm-diameter bladder tumor on the right bladder wall. b Macroscopic normal mucosa about 0.5 cm away from the tumor base was margined. Then, the bladder mucosa was subsequently cut in a “flash-firing” fashion. c After the deep muscle layer was reached when normal glistening yellow fat is seen between muscle layers, the loop was moved forward along the muscle layer. d The tumor was resected in one piece
Fig. 2
Fig. 2
Histologic findings of resected tumors. a The lamina propria mucosa was severely charred without muscular propria in a tumor in the C-TURBT group (×40). b The lamina propria mucosae remained intact, and the muscular propria was identified in a tumor in the RERBT group (×40)

References

    1. Rl S, Kd M, Aa J, Aa J. Cancer statistics. CA Cancer J Clin. 2015;65(1):5–29. doi: 10.3322/caac.21254.
    1. Xishuang S, Deyong Y, Xiangyu C, et al. Comparing the safety and efficiency of conventional monopolar, plasmakinetic, and holmium laser transurethral resection of primary non-muscle invasive bladder cancer. J Endourol. 2010;24(1):69–73. doi: 10.1089/end.2009.0171.
    1. Sureka SK, Agarwal V, Agnihotri S, et al. Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study. Indian J Urol. 2014;30(2):144–149. doi: 10.4103/0970-1591.126887.
    1. Babjuk M, Burger M, Zigeuner R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–653. doi: 10.1016/j.eururo.2013.06.003.
    1. Gontero P, Sylvester R, Pisano F, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guerin: results of a retrospective multicenter study of 2451 patients. Eur Urol. 2015;67(1):74–82. doi: 10.1016/j.eururo.2014.06.040.
    1. Herr HW, Donat SM. Quality control in transurethral resection of bladder tumours. BJU Int. 2008;102(9 Pt B):1242–1246. doi: 10.1111/j.1464-410X.2008.07966.x.
    1. Ornstein DK. Pathology and genetics: tumours of the urinary system and male genital organs. J Urol. 2004;172(6, Part 1):2511. doi: 10.1097/01.ju.0000145260.89322.2d.
    1. de Nunzio C, Franco G, Cindolo L, et al. Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort. Eur J Surg Oncol. 2014;40(1):90–95. doi: 10.1016/j.ejso.2013.11.003.
    1. Maurice MJ, Vricella GJ, MacLennan G, et al. Endoscopic snare resection of bladder tumors: evaluation of an alternative technique for bladder tumor resection*. J Endourol. 2012;26(6):614–617. doi: 10.1089/end.2011.0587.
    1. Bach T, Muschter R, Herrmann TR, et al. Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: Summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and future pers. BJU Int. 2015;115(1):14–23. doi: 10.1111/bju.12664.
    1. Kramer MW, Rassweiler JJ, Klein J, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015;33(12):1937–1943. doi: 10.1007/s00345-015-1568-6.
    1. Ukai R, Kawashita E, Ikeda H. A new technique for transurethral resection of superficial bladder tumor in 1 piece. J Urol. 2000;163(3):878–879. doi: 10.1016/S0022-5347(05)67824-X.
    1. Hurle R, Lazzeri M, Colombo P, et al. “En bloc” resection of nonmuscle invasive bladder cancer: a prospective single-center study. Urology. 2016;90:126–130. doi: 10.1016/j.urology.2016.01.004.
    1. Oh KJ, Choi Y-D, Chung HS, et al. A novel transurethral resection technique for superficial flat bladder tumor: grasp and bite technique. Korean J Urol. 2015;56(3):227–232. doi: 10.4111/kju.2015.56.3.227.
    1. Zhong C, Guo S, Tang Y, et al. Clinical observation on 2 micron laser for non-muscle-invasive bladder tumor treatment: single-center experience. World J Urol. 2010;28(2):157–161. doi: 10.1007/s00345-010-0532-8.
    1. Nagele U, Kugler M, Nicklas A, et al. Waterjet hydrodissection: first experiences and short-term outcomes of a novel approach to bladder tumor resection. World J Urol. 2011;29(4):423–427. doi: 10.1007/s00345-011-0653-8.
    1. Fritsche H-M, Otto W, Eder F, et al. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol. 2011;25(10):1599–1603. doi: 10.1089/end.2011.0042.
    1. Thomas K, O’Brien T. Improving transurethral resection of bladder tumour: the gold standard for diagnosis and treatment of bladder tumours. Eur Urol Suppl. 2008;7(7):524–528. doi: 10.1016/j.eursup.2008.04.003.
    1. Kramer MW, Wolters M, Herrmann TR (2016) En bloc resection of bladder tumors: ready for prime time? European urology. doi: 10.1016/j.eururo.2016.01.004
    1. Migliari R, Buffardi A, Ghabin H. Thulium laser endoscopic en bloc enucleation of nonmuscle-invasive bladder cancer. J Endourol. 2015;29(11):1258–1262. doi: 10.1089/end.2015.0336.
    1. Weizer AZ, Wasco MJ, Wang R, et al. Multiple adverse histological features increase the odds of under staging T1 bladder cancer. J Urol. 2009;182(1):59–65. doi: 10.1016/j.juro.2009.02.116.
    1. Coblentz TR, Mills SE, Theodorescu D. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma. Cancer. 2001;91(7):1284–1290. doi: 10.1002/1097-0142(20010401)91:7<1284::AID-CNCR1130>;2-E.
    1. BRAUERS A, BUETTNER R, Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol. 2001;165(3):808–810. doi: 10.1016/S0022-5347(05)66532-9.
    1. Muto G, Collura D, Giacobbe A, et al. Thulium: yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages. Urology. 2014;83(4):851–855. doi: 10.1016/j.urology.2013.12.022.
    1. Xu Y, Guan W, Chen W, et al. Comparing the treatment outcomes of potassium-titanyl-phosphate laser vaporization and transurethral electroresection for primary nonmuscle-invasive bladder cancer: a prospective, randomized study. Lasers Surg Med. 2015;47(4):306–311. doi: 10.1002/lsm.22342.
    1. Naselli A, Introini C, Germinale F, et al. En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm. BJU Int. 2012;109(6):960–963. doi: 10.1111/j.1464-410X.2012.10982.x.

Source: PubMed

3
Iratkozz fel